Phenylalkanoic compounds and therapeutic use thereof
AssigneeHommel Aktiengesellschaft
InventorsJean Heusser, Max Glasbrenner
Life of this patent
Estimating the term…
Abstract
Novel phenylalkanoic compounds of the formula I ##STR1## wherein R.sub.1 and R.sub.2 independently from each other represent hydrogen or alkyl with 1 to 8 carbon atoms, salts of such compounds and salts thereof, therapeutic uses of the phenylalkanoic compounds, or of the pharmacologically safe salts thereof for treating inflammatory diseases, tussive states, pain symptoms and pyretic diseases and pharmaceutical composition containing the phenylalkanoic compounds or the pharmacologically safe salts together with a carrier and an optional adjuvant or additive.
Claims8
A compound of the formula (I) ##STR6## wherein R.sub.1 and R.sub.2 independently from each other represent hydrogen or alkyl with 1 to 8 carbon atoms and pharmacologically safe salts of such compound.
A pharmaceutical composition comprising at least one compound of the formula (I) ##STR7## wherein R.sub.1 and R.sub.2 independently from each other represent hydrogen or alkyl with 1 to 8 carbon atoms or a pharmacologically safe salt of formula (I) compound;
- said composition further comprising an anti-inflammatorically, antitussively, analgesically and antipyretically effective amount of the active ingredient together with substances selected from the group consisting of pharmaceutical carriers suitable for oral, for parenteral or for topical administration.
A method of treating inflammatory diseases, pain symptoms, tussive states and pyretic diseases of a human patient, said method comprising administering an amount effective for curing or alleviating said diseases, to said patient an effective amount of a pharmaceutical composition comprising at least one compound of formula (I) ##STR8## wherein R.sub.1 and R.sub.2 independently from each other represent hydrogen or alkyl with 1 to 8 carbon atoms, or a pharmacologically safe salt thereof, said composition further comprising a substance selected from the group consisting of pharmaceutical carriers suitable for oral, for parenteral or for topical administration.
Dependencies are inferred from the claim text.